ReviewFrontiers in immunology2026
"From inflammation to fibrosis: a proposed role of mucosal-associated invariant T cells in lichen sclerosus - a conceptual framework".
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lichen sclerosus (LS) is a chronic inflammatory and fibrosing dermatosis with a well-documented autoimmune background and a dominant Th1/Th17-driven immune response. Despite growing insight into its immunopathogenesis, the mechanisms linking persistent inflammation to progressive fibrosis remain unclear. Mucosal-associated invariant T cells (MAIT cells) are innate-like lymphocytes enriched in epithelial tissues, characterized by rapid activation and robust production of proinflammatory cytokines. Although alterations in MAIT cells frequency and function have been described in autoimmune and fibrotic disorders, their role in LS has not yet been elucidated. This review integrates current knowledge on MAIT cells biology and proposes a conceptual framework for their potential involvement in LS, largely based on extrapolation from studies in other inflammatory and fibrotic conditions. We hypothesize that MAIT cells may contribute to disease progression by amplifying Th1/Th17 responses, promoting epithelial damage and indirectly supporting fibroblast activation through cytokine-mediated pathways, including the TGF-β axis. Furthermore, their responsiveness to microbial-derived ligands and inflammatory cytokines suggests a role in sustaining chronic immune activation within a dysregulated tissue microenvironment. Under chronic inflammatory conditions, MAIT cells may shift toward a proinflammatory and profibrotic phenotype, thereby contributing to the transition from inflammation to fibrosis. This hypothesis-generating framework requires experimental validation but may provide new insights into LS pathogenesis and potential therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.